Cramer's Ready to Buy - TheStreet

Cramer's Ready to Buy

Last week, everyone got too bullish on everything, so today you can expect that there will be selling of last week's winners. Perfect, Cramer says. He says sell them. Sell them hard. He's buying.
Author:
Publish date:

When

Jeff Berkowitz

asked me this morning at our meeting what I thought the market would do, I said, "the market will bet the house on the

Yanks

so we have to cover the

Braves

and go long." He understood instinctively. Last week, everyone got too bullish on everything, so today you can expect that there will be selling of last week's winners. Perfect. I say sell them. Sell them hard. I am buying.

Cramer's Latest: Join the discussion on

TSC

Message Boards.

The Net, drugs, the financials on weakness, these all make sense even as hardware tech seems to make little sense. I want in on the

Pfizer

(PFE) - Get Report

dislocation and I hope

Merck

(MRK) - Get Report

comes down big. I want in on these financials that selloff. I welcome a Net selloff to get in ahead of the holiday buying season.

All of these companies are flush with cash and soon they will be in buying back stock. Remember that

piece last week on

Kimberly-Clark

(KMB) - Get Report

? They will be buying back stock aggressively now that their quiet period is over. I want to be there.

Same with

J.P. Morgan

(JPM) - Get Report

. This company reported a great, great quarter and it has a ton of liquidity. It is priced too cheaply after that great quarter.

Same with

Allstate

(ALL) - Get Report

, which got upgraded by

Keefe Bruyette

this morning. Those guys don't move stocks when they upgrade. They just make you money. That's all that matters in my book.

So, go ahead. Take the Yanks for the next game. I want the Braves. Too many people selling them. I like the odds.

James J. Cramer is manager of a hedge fund and co-founder of TheStreet.com. At time of publication, his fund was long J.P. Morgan, Kimberly-Clark, Pfizer, Merck and Allstate. His fund often buys and sells securities that are the subject of his columns, both before and after the columns are published, and the positions that his fund takes may change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Cramer's writings provide insights into the dynamics of money management and are not a solicitation for transactions. While he cannot provide investment advice or recommendations, he invites you to comment on his column at

jjcletters@thestreet.com.